$298 Million is the total value of First Light Asset Management, LLC's 55 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 9.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AKRXQ | Sell | AKORN INC | $24,567,000 | +31.5% | 732,462 | -5.6% | 8.24% | +15.6% |
| NEO | Buy | NEOGENOMICS INC | $24,006,000 | +14.7% | 2,679,271 | +1.0% | 8.05% | +0.8% |
| ATRC | Buy | ATRICURE INC | $23,252,000 | +26.9% | 958,858 | +0.3% | 7.80% | +11.6% |
| IMMU | Sell | IMMUNOMEDICS INC | $18,090,000 | +33.4% | 2,048,643 | -2.3% | 6.07% | +17.2% |
| OMCL | Buy | OMNICELL INC | $11,994,000 | +120.5% | 278,294 | +108.0% | 4.02% | +93.7% |
| SHPG | Buy | SHIRE PLC | $11,489,000 | +18.2% | 69,519 | +24.6% | 3.86% | +3.9% |
| NKTR | Buy | NEKTAR THERAPEUTICS | $9,192,000 | +75.3% | 470,194 | +110.5% | 3.08% | +54.0% |
| HBIO | Buy | HARVARD BIOSCIENCE INC | $9,109,000 | +9.3% | 3,572,196 | +11.5% | 3.06% | -3.9% |
| OXFD | Sell | OXFORD IMMUNOTEC GLOBAL PLC | $8,822,000 | -8.5% | 524,509 | -15.7% | 2.96% | -19.6% |
| TLGT | Sell | TELIGENT INC | $8,678,000 | +17.0% | 948,455 | -0.1% | 2.91% | +2.8% |
| ENTL | Buy | ENTELLUS MEDICAL INC | $8,486,000 | +50.9% | 512,416 | +25.7% | 2.85% | +32.6% |
| SPNC | Buy | SPECTRANETICS CORP | $8,357,000 | +57.5% | 217,637 | +19.5% | 2.80% | +38.5% |
| XENT | Sell | INTERSECT ENT INC | $7,648,000 | -33.2% | 273,645 | -59.0% | 2.57% | -41.3% |
| LGND | Sell | LIGAND PHARMACEUTICALS INC | $7,602,000 | +14.7% | 62,623 | -0.0% | 2.55% | +0.8% |
| SAGE | Sell | SAGE THERAPEUTICS INC | $7,387,000 | +11.2% | 92,761 | -0.8% | 2.48% | -2.3% |
| KTWO | Sell | K2M GROUP HOLDINGS INC | $6,614,000 | +18.7% | 271,495 | -0.1% | 2.22% | +4.3% |
| VCYT | Buy | VERACYTE INC | $6,285,000 | -5.0% | 754,560 | +4.7% | 2.11% | -16.5% |
| LHCG | Sell | LHC GROUP INC | $6,240,000 | -8.2% | 91,917 | -27.1% | 2.09% | -19.3% |
| AMED | Sell | AMEDISYS INC | $5,812,000 | +22.9% | 92,535 | -0.0% | 1.95% | +8.0% |
| MODN | Buy | MODEL N INC | $5,629,000 | +28.0% | 423,211 | +0.6% | 1.89% | +12.5% |
| HALO | Buy | HALOZYME THERAPEUTICS INC | $5,341,000 | -0.6% | 416,579 | +0.5% | 1.79% | -12.6% |
| MDCO | Buy | MEDICINES COMPANY | $5,266,000 | -21.3% | 138,543 | +1.3% | 1.77% | -30.8% |
| HRTX | Buy | HERON THERAPEUTICS INC | $5,088,000 | -6.7% | 367,390 | +1.0% | 1.71% | -18.1% |
| HSTM | Sell | HEALTHSTREAM INC | $4,897,000 | -34.8% | 186,044 | -40.0% | 1.64% | -42.7% |
| ARRY | Buy | ARRAY BIOPHARMA INC | $4,785,000 | -5.5% | 571,629 | +0.9% | 1.60% | -17.0% |
| TECH | Sell | BIO TECHNE CORP | $4,488,000 | +15.6% | 38,194 | -0.0% | 1.51% | +1.6% |
| ENZ | Sell | ENZO BIOCHEM INC | $4,450,000 | -52.6% | 403,082 | -64.1% | 1.49% | -58.4% |
| NVRO | New | NEVRO CORP | $4,418,000 | – | 59,358 | +100.0% | 1.48% | – |
| NXTM | Buy | NXSTAGE MEDICAL INC | $4,301,000 | -5.7% | 171,578 | +0.9% | 1.44% | -17.1% |
| BLUE | Sell | BLUEBIRD BIO INC | $3,549,000 | -20.8% | 33,780 | -31.4% | 1.19% | -30.4% |
| VRTX | Sell | VERTEX PHARMACEUTICALS INC | $2,979,000 | +17.8% | 23,119 | -0.0% | 1.00% | +3.4% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $2,867,000 | +3.4% | 31,567 | -0.1% | 0.96% | -9.2% |
| IBB | ISHARES NASDAQ BIOTECHNOLOGY ETFetf | $2,200,000 | +5.7% | 7,097 | 0.0% | 0.74% | -7.2% | |
| IONS | Sell | IONIS PHARMACEUTICALS INC | $2,137,000 | +5.9% | 42,015 | -16.3% | 0.72% | -6.9% |
| QDEL | Sell | QUIDEL CORP | $2,014,000 | +19.6% | 74,201 | -0.2% | 0.68% | +5.1% |
| NSTG | Sell | NANOSTRING TECHNOLOGIES INC | $1,897,000 | -16.8% | 114,702 | -0.0% | 0.64% | -26.9% |
| STRM | Buy | STREAMLINE HEALTH SOLUTIONS | $1,896,000 | +13.6% | 1,771,550 | +8.3% | 0.64% | -0.2% |
| CELG | CELGENE CORP | $1,779,000 | +4.3% | 13,701 | 0.0% | 0.60% | -8.3% | |
| ALKS | Buy | ALKERMES PLC | $1,722,000 | -0.9% | 29,700 | +0.0% | 0.58% | -12.8% |
| PSCH | POWERSHARES S&P SMALLCAP HEALTH CARE ETFetf | $1,519,000 | +9.8% | 17,285 | 0.0% | 0.51% | -3.4% | |
| CDXS | New | CODEXIS INC | $1,499,000 | – | 274,990 | +100.0% | 0.50% | – |
| XLV | HEALTH CARE SELECT SECTOR SPDR ETFetf | $1,445,000 | +6.6% | 18,241 | 0.0% | 0.48% | -6.4% | |
| LMAT | Buy | LEMAITRE VASCULAR INC | $1,443,000 | +26.8% | 46,234 | +0.1% | 0.48% | +11.5% |
| IHI | ISHARES US MEDICAL DEVICES ETFetf | $1,263,000 | +10.0% | 7,580 | 0.0% | 0.42% | -3.2% | |
| MGNX | Buy | MACROGENICS INC | $1,078,000 | -5.8% | 61,538 | +0.1% | 0.36% | -17.2% |
| IRIX | New | IRIDEX CORP | $997,000 | – | 100,830 | +100.0% | 0.33% | – |
| XBI | SPDR S&P BIOTECH ETFetf | $733,000 | +11.2% | 9,499 | 0.0% | 0.25% | -2.4% | |
| TEAR | Sell | TEARLAB CORP | $702,000 | -41.3% | 420,066 | -0.2% | 0.24% | -48.4% |
| SNY | SANOFI-SYNTHELABO | $322,000 | +5.9% | 6,720 | 0.0% | 0.11% | -6.9% | |
| ABBV | ABBVIE | $302,000 | +11.4% | 4,159 | 0.0% | 0.10% | -1.9% | |
| NVS | NOVARTIS A G | $298,000 | +12.5% | 3,572 | 0.0% | 0.10% | -1.0% | |
| JNJ | JOHNSON AND JOHNSON | $289,000 | +6.2% | 2,183 | 0.0% | 0.10% | -6.7% | |
| PFE | PFIZER INC | $287,000 | -2.0% | 8,558 | 0.0% | 0.10% | -14.3% | |
| DYNT | New | DYNATRONICS CORP | $280,000 | – | 100,000 | +100.0% | 0.09% | – |
| MRK | MERCK & CO INC | $275,000 | +0.7% | 4,294 | 0.0% | 0.09% | -11.5% | |
| CEMI | Exit | CHEMBIO DIAGNOSTICS INC | $0 | – | -55,452 | -100.0% | -0.11% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ATRICURE INC | 40 | Q3 2023 | 9.7% |
| NEOGENOMICS INC | 40 | Q3 2023 | 10.6% |
| SANOFI-SYNTHELABO | 40 | Q3 2023 | 1.9% |
| JOHNSON & JOHNSON | 40 | Q3 2023 | 0.3% |
| PFIZER INC | 39 | Q2 2023 | 0.9% |
| BIOMARIN PHARMACEUTICAL INC | 36 | Q3 2023 | 1.6% |
| OMNICELL INC | 33 | Q3 2023 | 7.7% |
| QUIDEL CORP | 33 | Q4 2021 | 3.7% |
| NOVARTIS AG-SPONSORED ADR | 33 | Q3 2023 | 0.4% |
| MODEL N INC | 30 | Q3 2023 | 9.0% |
View First Light Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| REATA PHARMACEUTICALS INC | May 15, 2023 | 1,290,193 | 3.9% |
| Axogen, Inc. | February 03, 2023 | 1,942,270 | 4.6% |
| MODEL N, INC. | February 03, 2023 | 1,845,134 | 4.9% |
| MEI Pharma, Inc.Sold out | May 31, 2022 | 0 | 0.0% |
| PROTHENA CORP PUBLIC LTD CO | March 01, 2022 | 1,805,038 | 3.9% |
| Intersect ENT, Inc. | February 14, 2022 | 1,375,210 | 4.1% |
| SeaSpine Holdings Corp | February 14, 2022 | 6,847,707 | 18.8% |
| Oxford Immunotec Global PLCSold out | February 10, 2021 | 0 | 0.0% |
| ENDOLOGIX INC /DE/ | February 14, 2020 | 816,236 | 4.6% |
| Nuvectra CorpSold out | February 14, 2020 | 0 | 0.0% |
View First Light Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-09 |
| 4 | 2024-04-08 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
View First Light Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.